Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
US Army
Queensland Health
Chinese Patent Office
Colorcon
Dow
Farmers Insurance
QuintilesIMS
Merck

Generated: June 24, 2018

DrugPatentWatch Database Preview

SCANDONEST PLAIN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Scandonest Plain, and when can generic versions of Scandonest Plain launch?

Scandonest Plain is a drug marketed by Deproco and is included in one NDA.

The generic ingredient in SCANDONEST PLAIN is mepivacaine hydrochloride. There are six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the mepivacaine hydrochloride profile page.
Summary for SCANDONEST PLAIN
Drug patent expirations by year for SCANDONEST PLAIN
Pharmacology for SCANDONEST PLAIN
Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia
Medical Subject Heading (MeSH) Categories for SCANDONEST PLAIN
Synonyms for SCANDONEST PLAIN
(+-)-1-Methyl-2',6'-pipecoloxylidide monohydrochloride
(+/-)-Mepivacaine hydrochloride, >=98% (HPLC)
(1-Methyl-DL-piperidine-2-carboxylic acid)-2,6-dimethylanilide hydrochloride
(1-methyl-dl-piperidine-2-carboxylicacid)-2,6-dimethylanilidehydrochloride
1-methyl-2 inverted exclamation mark ,6 inverted exclamation mark -pipecoloxylididehydrochloride
1-Methyl-2 inverted exclamation marka,6 inverted exclamation marka-pipecoloxylidine hydrochloride
1-Methyl-2',6'-pipecoloxylidide hydrochloride
1-Methyl-2',6'-pipecoloxylidide monohydrochloride
1-Methyl-2',6'-pipecoloxylidine hydrochloride
16452-56-5
1722-62-9
2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, monohydrochloride
2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, monohydrochloride, (+-)-
2',6'-Pipecoloxylidide, 1-methyl -, monohydrochloride
38423-99-3
6 inverted exclamation mark -pipecoloxylidide,1-methyl-2monohydrochloride
722M629
96-88-8 (Parent)
A811391
AB0012058
AC-2102
AC1L24K2
ACT02686
AK-61115
AKOS015889311
AN-14290
ANW-46921
API0003297
Arestocaine hydrochloride
AX8032267
BC220537
BG0250
BR-61115
C-17796
Carbocaina
Carbocaine (TN)
Carbocaine hydrochloride
Carbocaine monohydrochloride
carbocainehydrochloride
CAS-1722-62-9
CC-30208
CCG-101083
CCG-39081
CHEBI:6760
CHEMBL1200440
Chlorocain
CPD000058904
CS-2729
CTK8B4971
D00738
dl-1-methyl-2 inverted exclamation mark ,6 inverted exclamation mark -pipecoloxylididehydrochloride
dl-mepivacainehydrochloride
DSSTox_CID_11566
DSSTox_GSID_31566
DSSTox_RID_78885
DTXSID4031566
EINECS 217-023-9
FT-0080089
FT-0601566
HE222297
HMS1922D17
HY-B0517A
I01-1865
ISOCAINE HYDROCHLORIDE
KS-00001F7F
KS-1271
LS-2120
M2560
MCULE-4459584385
Meaverin
Mepicaton
Mepident
mepivacain hydrochloride
Mepivacaine (hydrochloride)
Mepivacaine chlorhydrate
Mepivacaine HCL
Mepivacaine hydrochloride
Mepivacaine hydrochloride (JP17/USP)
Mepivacaine hydrochloride [USAN:JAN]
Mepivacaine hydrochloride [USP:JAN]
Mepivacaine hydrochloride, 98.0-102.0%, meets USP testing specifications
Mepivacaine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Mepivacaine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Mepivacaine Monohydrochloride
Mepivacaine(hydrochloride)
MepivacaineHCL//Mepivacaine
Mepivastesin
Mepivicaine hydrochloride
MEPIVICAINE HYDROCHLORIDE (MEPIVICAINE (96-88-8))
MFCD00144738
MLS000028662
MLS001074068
MLS001424226
MolPort-003-666-532
N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide hydrochloride
n-(2,6-dimethylphenyl)-1-methyl-2-piperidinecarboxamidmonohydrochloride
N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide hydrochloride
N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide hydrochloride
N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide hydrochloride (1:1)
N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide;hydrochloride
N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamidehydrochloride
N-(2,6-dimethylphenyl)(1-methyl(2-piperidyl))carboxamide, chloride
NC00333
NCGC00095108-01
NCGC00095108-02
NCGC00095108-03
NSC-758674
NSC758674
Opera_ID_1165
Optocain
Pharmakon1600-01504148
Polocaine (TN)
Q-201354
RETIMRUQNCDCQB-UHFFFAOYSA-N
S-6505
s3155
Sabol
SAM001246875
SBB057000
SC-13935
Scandinibsa
Scandonest
Scandonest plain (TN)
SCHEMBL34245
SMR000058904
SPECTRUM1504148
ST2419639
ST50993897
TC-135666
Tox21_111424

US Patents and Regulatory Information for SCANDONEST PLAIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Deproco SCANDONEST PLAIN mepivacaine hydrochloride INJECTABLE;INJECTION 088387-001 Oct 10, 1984 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Healthtrust
Deloitte
Cerilliant
Mallinckrodt
Julphar
Federal Trade Commission
US Army
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.